cases of ulcerative colitis) and 38 matched healthy subjects (control group) were considered
for study. MDA levels were quantified by the measurement of thiobarbituric acid reactive
substances. Results: Plasma MDA levels of Crohn′ s disease patients were significantly
higher than the control group, but not higher than the ulcerative colitis patients. Plasma MDA
levels of patients with ulcerative colitis were higher than the control group but not significant …